AbsEn.i
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (France)

Index « AbsEn.i » - entrée « every »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
ever < every < everyday  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000097 (2019) Ernest Choy [Royaume-Uni] ; Nick Freemantle [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Laurence Pollissard [France] ; Andreas Kuznik [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Erin Mangan [États-Unis] ; Paulo Carita [France] ; Thi-Minh-Thao Huynh [France]Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs
000103 (2019) Ernest Choy [Royaume-Uni] ; Nick Freemantle [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Laurence Pollissard [France] ; Andreas Kuznik [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Erin Mangan [États-Unis] ; Paulo Carita [France] ; Thi-Minh-Thao Huynh [France]Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature review and network meta-analyses
000190 (2018) Cem Gabay [Suisse] ; Jérôme Msihid [France] ; Moshe Zilberstein [États-Unis] ; Caroline Paccard [France] ; Yong Lin [États-Unis] ; Neil M H. Graham [États-Unis] ; Anita Boyapati [États-Unis]Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET study
000369 (2015) A-P Trouvin ; S. Jacquot [France] ; S. Grigioni [France] ; E. Curis [France] ; I. Dedreux [France] ; A. Roucheux [France] ; H. Boulard ; O. Vittecoq [France] ; X. Le Loët ; O. Boyer [France] ; V. Goëb [France]Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study
000410 (2015) Vivian P. Bykerk [États-Unis] ; Andrew J. K. Östör [Royaume-Uni] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Winfried Graninger [Autriche] ; William Bensen ; Michael T. Nurmohamed [Pays-Bas] ; Andreas Krause [Allemagne] ; Corrado Bernasconi [Suisse] ; Maher Aassi [Suisse] ; Jean Sibilia [France]Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice
000426 (2014) C. Le Stradic [France] ; C. Galeotti [France] ; I. Koné-Paut [France][Tocilizumab: experience in a French rheumatological pediatric center].
000436 (2014) Juan P. Mackern-Oberti ; Fabián Vega ; Carolina Llanos ; Susan M. Bueno [France] ; Alexis M. Kalergis [France]Targeting Dendritic Cell Function during Systemic Autoimmunity to Restore Tolerance
000491 (2013) Martin Soubrier [France] ; Zuzana Tatar ; Marion Couderc ; Sylvain Mathieu ; Jean-Jacques DubostRheumatoid arthritis in the elderly in the era of tight control.
000608 (2013) Martin Soubrier [France] ; Zuzana Tatar [France] ; Marion Couderc [France] ; Sylvain Mathieu [France] ; Jean-Jacques Dubost [France]Rheumatoid Arthritis in the Elderly in the Era of Tight Control
000613 (2012) Caroline Galeotti [France] ; Adeline Boucheron ; Séverine Guillaume ; Isabelle Koné-PautSustained remission of multicentric Castleman disease in children treated with tocilizumab, an anti-interleukin-6 receptor antibody.
000642 (2012) Nicolino Ruperto [Italie] ; Pierre Quartier [France] ; Nico Wulffraat [Pays-Bas] ; Patricia Woo [Royaume-Uni] ; Angelo Ravelli [Italie] ; Richard Mouy [France] ; Brigitte Bader-Meunier [France] ; Sebastiaan J. Vastert [Pays-Bas] ; Emanuele Noseda [Suisse] ; Daniele D'Ambrosio [Suisse] ; Jean Lecot [Suisse] ; Abhijit Chakraborty [Suisse] ; Alberto Martini [Italie] ; Andrea Chioato [Suisse]A phase II, multicenter, open‐label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
000648 (2012) Christophe Richez [France] ; Thomas Barnetche ; Liliane Khoryati ; Pierre Duffau ; Marie Kostine ; Cécile Contin-Bordes ; Patrick Blanco ; Thierry SchaeverbekeTocilizumab Treatment Decreases Circulating Myeloid Dendritic Cells and Monocytes, 2 Components of the Myeloid Lineage
000681 (2011) Brahim Selmaoui [France] ; Jacques Lambrozo [France] ; Linda Sackett-Lundeen [États-Unis] ; Erhard Haus [États-Unis] ; Yvan Touitou [France]Acute Exposure to 50-Hz Magnetic Fields Increases Interleukin-6 in Young Healthy Men
000695 (2011) Xavier Puechal [France] ; Michel De Bandt [France] ; Jean-Marie Berthelot [France] ; Maxime Breban [France] ; Jean-Jacques Dubost [France] ; Olivier Fain [France] ; Jean-Emmanuel Kahn [France] ; Laurence Lequen [France] ; Maïté Longy-Boursier [France] ; Aleth Perdriger [France] ; Thierry Schaeverbeke [France] ; Eric Toussirot [France] ; Jean Sibilia [France]Tocilizumab in Refractory Adult Still's Disease
000699 (2011) Robert Launois [France] ; Bernard Avouac ; Francis Berenbaum ; Olivier Blin ; Isabelle Bru ; Bruno Fautrel ; Jean-Michel Joubert ; Jean Sibilia ; Bernard CombeComparison of Certolizumab Pegol with Other Anticytokine Agents for Treatment of Rheumatoid Arthritis: A Multiple-treatment Bayesian Metaanalysis
000725 (2010) Patrick Garnero [France] ; Elizabeth Thompson [Royaume-Uni] ; Thasia Woodworth [Royaume-Uni] ; Josef S. Smolen [Autriche]Rapid and Sustained Improvement in Bone and Cartilage Turnover Markers With the Anti-Interleukin-6 Receptor Inhibitor Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate: Results From a Substudy of the Multicenter Double-Blind, Placebo-Controlled Trial of Tocilizumab in Inadequate Responders to Methotrexate Alone

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/AbsEn.i -k "every" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/AbsEn.i  \
                -Sk "every" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    every
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021